UroGen Pharma (URGN) Net Long-Term Debt Issued (Repaid) (2022 - 2026)
UroGen Pharma (URGN) posted Non-Current Debt of $188.73 million for Q2 2026, up 54.1% from $122.51 million a year earlier but down 0.4% from the prior quarter.
Powered by 
Analysis
UroGen Pharma (URGN) Net Long-Term Debt Issued (Repaid) (2022 - 2026) Analysis & Trends
At the end of FY2025, UroGen Pharma's Non-Current Debt came in at $122.21 million, up 0.4% from FY2024.
- Annual Non-Current Debt has increased for three consecutive years, with a three-year compound annual growth rate of 7.8% (FY2022 to FY2025).
- In prior years, UroGen Pharma's Non-Current Debt was $121.73 million in FY2024 (+23.5%), $98.55 million in FY2023 (+1.0%) and $97.54 million in FY2022.
- Quarterly Non-Current Debt has run from a low of $70.8 million in Q1 2022 to a high of $189.53 million in Q1 2026 over five years.
- On a year-over-year basis, Non-Current Debt has increased in each of the last eight quarters, with growth averaging 25.9% over the last eight quarters.
- The strongest year-over-year quarter for Non-Current Debt in the past five years was Q1 2026, with growth of 55.2%; the weakest was Q2 2024, with a decline of 0.5%.
- According to Business Quant data, Non-Current Debt for the three prior quarters was $189.53 million (Q1 2026), $122.21 million (Q4 2025) and $122.11 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net LT Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn | - |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn | -1.00 Mn |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn | 9.98 Bn |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn | - |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn | 1.96 Bn |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn | - |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn | -3.05 Bn |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn | -19.00 Mn |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn | - |
| 10 | UroGen Pharma | 1.31 Bn | 855.26 Mn | 81.50 Mn | -616,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | -616,000.00 |
| Jun 30, 2026 | -387,000.00 |
| Mar 31, 2026 | 65.03 Mn |
| Mar 31, 2025 | -688,000.00 |
| Dec 31, 2022 | 24.99 Mn |
| Jun 30, 2022 | -38,000.00 |
| Mar 31, 2022 | 70.83 Mn |
API Access
UroGen Pharma Net Long-Term Debt Issued (Repaid) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-debt&ticker=URGN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-debt", "ticker": "URGN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-debt&ticker=URGN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();